Composition
- Active ingredients
- CHLORPROTHIXENE 100MG/5ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CHLORPROTHIXENE 12.5MG/ML · InjectableNDA012487-001 · Discontinued
- CHLORPROTHIXENE 100MG/5ML · ConcentrateThis page
- CHLORPROTHIXENE 100MG · TabletNDA012486-001 · Discontinued
- CHLORPROTHIXENE 25MG · TabletNDA012486-004 · Discontinued
- CHLORPROTHIXENE 10MG · TabletNDA012486-005 · Discontinued
- CHLORPROTHIXENE 50MG · TabletNDA012486-003 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA016149.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Taractan
- Active substance
- chlorprothixene
- Route
- Oral
- Dosage form
- Concentrate
- Applicant
- Roche
- Status
- Discontinued
- FDA approval
- 19 Jun 1967
- Application
- NDA016149-002